Stephanie Justus
Family · Mount Vernon, MONPI 1629452107
Payments from drug & device makers
Across 347 payments — averaging $17.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$781
- Neurocrine Biosciences, Inc.$577
- AbbVie$573
- Pfizer$350
- Otsuka America Pharmaceutical, Inc.$301
- Astellas Pharma US Inc$291
- plus $3K from 47 others
What the payments were for
- Food & beverage$6,01698%
- Education$1052%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,121 in reported general payments places this provider in the 95th percentile of 3,812 family providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 82 | $71,883 |
| TrulicityDulaglutide | 33 | $54,808 |
| EliquisApixaban | 61 | $44,254 |
| RexultiBrexpiprazole | 28 | $40,552 |
| MounjaroTirzepatide | 29 | $39,776 |
| XareltoRivaroxaban | 49 | $37,748 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 35 | $34,185 |
| OzempicSemaglutide | 21 | $28,883 |
| JanuviaSitagliptin Phosphate | 20 | $27,863 |
| JardianceEmpagliflozin | 12 | $20,374 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 14 | $19,455 |
| RybelsusSemaglutide | 17 | $15,735 |
| LyricaPregabalin | 16 | $14,285 |
| VascepaIcosapent Ethyl | 17 | $13,079 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 21 | $9,803 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $109 | $94,58462 claims |
| AstraZenecaFarxiga | $781 | $71,88382 claims |
| PfizerEliquis, Lyrica, Premarin | $350 | $63,46993 claims |
| Novo NordiskOzempic, Rybelsus | $78 | $44,61838 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Arnuity Ellipta | $48 | $40,69360 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $301 | $40,55228 claims |
| Johnson & JohnsonXarelto | $204 | $37,74849 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat, Stiolto Respimat | $57 | $34,20238 claims |
| MerckJanuvia | $139 | $27,86320 claims |
| AbbVieLinzess, Synthroid | $573 | $8,73538 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,812 family providers in Missouri.
Other family in Mount Vernon
- Connie SpencerSaint Joseph$320K
- Shayla SandersKansas City$306K
- Tamera WolfLees Summit$215K
- Tiffany ArnoldFestus$177K
- Tiffany NelsonSedalia$164K
- Chelsey BeckerSaint Peters$104K
- Carey PattonDes Peres$94K
- Marcy MarkesColumbia$92K
- Laura HedigerSpringfield$71K
- Rebecca SeabaughSaint Louis$68K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.